Otolaryngologic Clinics of North America (Otolaryngol Clin )

Publisher: Elsevier

Description

Each issue of Otolaryngologic Clinics reviews new diagnostic and management techniques for a single clinical problem--and makes them simple to apply. Its concise, comprehensive, and its editors and authors are respected experts.

  • Impact factor
    1.46
  • 5-year impact
    1.77
  • Cited half-life
    8.90
  • Immediacy index
    0.26
  • Eigenfactor
    0.00
  • Article influence
    0.55
  • Website
    Otolaryngologic Clinics website
  • Other titles
    Otolaryngologic clinics of North America
  • ISSN
    1557-8259
  • OCLC
    1761575
  • Material type
    Series, Internet resource
  • Document type
    Journal / Magazine / Newspaper, Internet Resource

Publisher details

Elsevier

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Voluntary deposit by author of pre-print allowed on Institutions open scholarly website and pre-print servers
    • Voluntary deposit by author of authors post-print allowed on institutions open scholarly website including Institutional Repository
    • Deposit due to Funding Body, Institutional and Governmental mandate only allowed where separate agreement between repository and publisher exists
    • Set statement to accompany deposit
    • Published source must be acknowledged
    • Must link to journal home page or articles' DOI
    • Publisher's version/PDF cannot be used
    • Articles in some journals can be made Open Access on payment of additional charge
    • NIH Authors articles will be submitted to PMC after 12 months
    • Authors who are required to deposit in subject repositories may also use Sponsorship Option
    • Pre-print can not be deposited for The Lancet
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: The Vibrant Soundbridge is a means to rehabilitate patients with sensorineural hearing loss. It differs from hearing aids in that it uses mechanical energy rather than acoustic sound to deliver better sound quality to the inner ear. The implant's crucial component is a floating mass transducer that is directly fixed to the incus to drive it, which is introduced into the middle ear through a facial recess approach. Although this is a newer technology, studies thus far have demonstrated better hearing results compared with hearing aids in terms of functional gain and speech intelligibility, and better outcomes on subjective assessments.
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article describes outcomes for the Otologics active middle ear implant for the semi-implantable and fully implantable (Carina, Otologics LLC, Boulder, CO) devices. Inclusion and exclusion criteria are reported in detail for surgical and audiologic management. Results from the clinical trial demonstrated no change for unaided air and bone conduction thresholds and no significant change in monosyllabic word scores or sentences in noise. Experiments are reported for conductive and mixed types of hearing losses in animal and human cadaveric models. These devices are in their infancy, and further study is needed to better identify candidates and develop appropriate expectations.
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: For many hearing-impaired individuals, the benefits of conventional amplification may be limited by acoustic feedback, occlusion effect, and/or ear discomfort. The MAXUM system and other implantable hearing devices have been developed as an option for patients who derive inadequate assistance from traditional HAs, but who are not yet candidates for cochlear implants. The MAXUM system is based on the SOUNDTEC Direct System technology, which has been shown to provide improved functional gain as well as reduced feedback and occlusion effect compared to hearing aids. This and other implantable hearing devices may have increasing importance as future aural rehabilitation options.
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Common disorders seen in frequently have related comorbid psychosocial issues and conditions. This article reviews the literature on these comorbidities in commonly seen otolaryngology conditions and heightens awareness of the cognitive, developmental, behavioral, emotional, and social correlates of these commonly treated conditions. Evidence-based practice would suggest identification and appropriate referrals would be helpful; therefore, a time-efficient and accurate screening mechanism is needed within the context of a busy clinical practice. A screening algorithm for identifying these issues and providing appropriate referrals is provided.
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Active middle ear implants (AMEIs) are sophisticated technologies designed to overcome many of the shortcomings of conventional hearing aids, including feedback, distortion, and occlusion effect. Three AMEIs are currently approved by the US Food and Drug Administration for implantation in patients with sensorineural hearing loss. In this article, the history of AMEI technologies is reviewed, individual component development is outlined, past and current implant systems are described, and design and implementation successes and dead ends are highlighted. Past and ongoing challenges facing AMEI development are reviewed.
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Oropharyngeal dysphagia (OPD) is a challenging and relatively common condition in children. Both developmentally normal and delayed children may be affected. The etiology of OPD is frequently multifactorial with neurologic, inflammatory, and anatomic conditions contributing to discoordination of the pharyngeal phase of swallowing. Depending on the severity and source, OPD may persist for several years with significant burden to a patient's health and family. This article details current understanding of the mechanism and potential sources of OPD in children while providing an algorithm for managing it in the acute and chronic setting.
    Otolaryngologic Clinics of North America 10/2014; 47(5):691–720.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the most current practice guidelines in the diagnosis and management of patients born with cleft lip and/or palate. Such patients frequently have multiple medical and social issues that benefit greatly from a team approach. Common challenges include feeding difficulty, nutritional deficiency, speech disorders, hearing problems, ear disease, dental anomalies, and both social and developmental delays, among others. Interdisciplinary evaluation and collaboration throughout a patient's development are essential.
    Otolaryngologic Clinics of North America 10/2014; 47(5):821–852.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Vibrant Soundbridge is the world's most often implanted active middle ear implant or hearing aid. During the last few years, the device indications have expanded from sensorineural hearing loss to conductive and mixed hearing loss. Titanium couplers have led to improved contact of the floating mass transducer with the middle ear structures. The resulting hearing gain is satisfying for most patients, but so far, there is no clear audiologic advantage over conventional hearing aids. Currently, the indications are mainly related to intolerance of conventional hearing aids (eg, chronic otitis externa), severe mixed hearing loss with a destructed middle ear and certain medical diagnosis (eg, congenital atresia).
    Otolaryngologic Clinics of North America 10/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article discusses the Envoy Esteem implantable hearing system, a completely implantable hearing device. The device is indicated for patients older than 18 years with stable moderate to severe sensorineural hearing loss and good speech discrimination. The device is placed through an intact canal wall tympanomastoidectomy with a wide facial recess approach. The implant is typically activated at 6 to 8 weeks postoperatively and usually requires several adjustments for optimal performance. The sound processor/battery lasts 4.5 to 9.0 years and can be replaced through a minor outpatient procedure.
    Otolaryngologic Clinics of North America 09/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cases are presented in light of the current diagnostic and therapeutic trends in management of thyroid nodules and well-differentiated cancers. Demographic, historical, and population-based risk factors are used to risk stratify cases. Ultrasonographic features and other imaging are discussed with regard to appropriateness of utilization and impact on management. The role of traditional cytologic and histopathologic analysis with fine-needle aspiration and intraoperative frozen sections is discussed, including diagnostic nuances and limitations. The emerging role of biomarkers such as Braf are evaluated regarding their role in contemporary assessment of thyroid nodules by reviewing practical cases.
    Otolaryngologic Clinics of North America 08/2014; 47(4):609–623.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Thyroid cancer is the most common endocrine malignancy and its incidence has increased over the past few decades. Most patients with thyroid cancer have an excellent prognosis, but there is a 15% recurrence rate within 10 years after initial treatment and mortality is possible. To date, there are no prospective, well-defined data supporting the use of molecular markers alone to decide the extent of treatment of patients with thyroid cancer or to predict the individual prognosis of these patients. Molecular markers are promising in the development of new targeted therapies particularly for radioiodine-refractory and unresectable thyroid cancers.
    Otolaryngologic Clinics of North America 08/2014; 47(4):595–607.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fine needle aspiration biopsy (FNA) is the key step in selecting most patients with thyroid nodules for or against surgery. Accurate acquisition of cytologic samples from suspicious lesions is achieved by adding ultrasound guidance to optimize targeting as well as to enable sampling from nonpalpable lesions. This article discusses the indications, variations, and technical details of ultrasound-guided FNA.
    Otolaryngologic Clinics of North America 08/2014; 47(4):509–518.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article is intended to demystify the process for those with a potential interest in acquiring ultrasound skills. It is not intended to be a comprehensive review of head and neck ultrasound but, rather, is focused on the bare minimum requirements and considerations involved in clinician-performed ultrasound. The article covers the initial diagnosis and the unparalleled usefulness of ultrasound for surgical planning just before incision. Further readings are listed at the end of the article to direct the reader to some excellent texts to help build confidence and experience.
    Otolaryngologic Clinics of North America 08/2014; 47(4):491–507.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the most current literature on thyroid nodule evaluation, with particular attention to the problem of the incidentally identified thyroid nodule. Although traditional risk factors for thyroid cancer, such as age, gender, and familial syndromes, are still important, the manner in which a thyroid nodule comes to attention is of great importance these days when considering how to proceed in a workup. Most thyroid nodules today are discovered through radiologic imaging tests performed for other reasons. This article covers the key considerations that are vital in balancing the risks and benefits of thyroid nodule workup and treatment.
    Otolaryngologic Clinics of North America 08/2014; 47(4):461–474.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The management of regional lymph nodes in thyroid carcinoma is guided by preoperative evaluation, histologic subtype, and often a consideration of data for potential benefit and morbidity of a neck dissection. The goal of lymphadenectomy is complete surgical resection of grossly evident metastatic disease and the removal of regional lymph node groups at highest risk for microscopic disease. Surgery should achieve disease eradication but preserve voice, airway, swallowing, and parathyroid function. This article discusses recommendations for addressing cervical lymph nodes in thyroid carcinoma, discusses current literature regarding the common histologic subtype (papillary carcinoma), and details our operative approach.
    Otolaryngologic Clinics of North America 08/2014; 47(4):545–556.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article covers, in a comprehensive way, thyroid cytopathology. The Bethesda System for Reporting Thyroid Cytology is reviewed, with emphasis on the atypical and indeterminate diagnostic categories. Immunohistochemistry stains and molecular tests panels applicable to cytology specimens are described.
    Otolaryngologic Clinics of North America 08/2014; 47(4):475–489.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article outlines features of the biology of well differentiated thyroid cancer, and how these impact on systems of risk prediction. It covers salient points that the surgeon should consider from the clinical history and examination in the office, and outlines the procedures available for surgical management of thyroid cancer. The article then examines the choices that face thyroid surgeons both in relation to planning primary thyroid surgery and the approach to regional lymphadenectomy. In addition, key findings in the operating room are discussed in relation to their impact on decision making. Long-term outcomes are presented for patients following surgery.
    Otolaryngologic Clinics of North America 08/2014; 47(4):519–528.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent technologic advances have engendered alternative and innovative approaches to thyroid surgery aimed at reducing cosmetic sequelae. Minimally invasive techniques via small anterior cervical incisions hidden in natural skin creases and remote access approaches that eliminate anterior neck incisions entirely have emerged as viable options for patients who regard cosmesis as a priority. The safe application of these techniques to both benign and malignant thyroid disease has been evaluated.
    Otolaryngologic Clinics of North America 08/2014; 47(4):529–544.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Thyroid fine-needle aspiration biopsies are cytologically indeterminate in 15% to 30% of cases. When cytologically indeterminate thyroid nodules undergo diagnostic surgery, approximately three-quarters prove to be histologically benign. A negative predictive value of more than or equal to 94% for the Afirma Gene Expression Classifier (GEC) is achieved for indeterminate nodules. Most Afirma GEC benign nodules can be clinically observed, as suggested by the National Comprehensive Cancer Network Thyroid Carcinoma Guideline. More than half of the benign nodules with indeterminate cytology (Bethesda categories III/IV) can be identified as GEC benign and removed from the surgical pool to prevent unnecessary diagnostic surgery.
    Otolaryngologic Clinics of North America 08/2014; 47(4):573–593.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article introduces and evaluates the feasibility of robot-assisted neck dissection as well as robot-assisted neck surgery via a modified facelift or retroauricular approach. Robot-assisted neck surgery is feasible compared with conventional techniques and shows a clear cosmetic benefit.
    Otolaryngologic Clinics of North America 06/2014; 47(3):433-454.